Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows

smart city and communication network. Smart city dot point connect .internet of things connection metaverse technology.

A three-drug combination that sent chronic lymphocytic leukemia (CLL) into deep remission in a broad group of patients in a clinical trial is highly effective in patients with high-risk forms of the disease, a new, phase 2 clinical trial led by Dana-Farber Cancer Institute investigators indicates.

Extending chemo slashes risk of aggressive childhood leukemia coming back

Previous article

Wordle today: Here’s the answer, hints for December 11

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations